<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The immunocytochemical study of thrombomodulin (TM), a newly recognized <z:chebi fb="3" ids="50249">anticoagulant</z:chebi> endothelial surface protein, was performed with a surgical specimen of a superficial temporal artery (STA) obtained from a 29-year-old woman with familial <z:e sem="disease" ids="C0026654" disease_type="Disease or Syndrome" abbrv="MYMY|MYMY1">moyamoya disease</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>The staining of TM showed positive immunoreactivity in smaller vessels in the surrounding connective tissue of the specimen, whereas negative in STA </plain></SENT>
<SENT sid="2" pm="."><plain>Immunoelectronmicroscopically the <z:chebi fb="2" ids="8069">luminal</z:chebi> plasma membrane of endothelial cells was positive for TM </plain></SENT>
<SENT sid="3" pm="."><plain>These staining pattern was the same as that in controls </plain></SENT>
<SENT sid="4" pm="."><plain>She concurrently suffered from <z:e sem="disease" ids="C0042974" disease_type="Disease or Syndrome" abbrv="">von Willebrand disease</z:e> type I, and she had two cerebral hemorrhagic attacks </plain></SENT>
<SENT sid="5" pm="."><plain>A quantitative defect of the <z:e sem="disease" ids="C0042974" disease_type="Disease or Syndrome" abbrv="">von Willebrand</z:e> factor in the endothelium was demonstrated immunocytochemically </plain></SENT>
</text></document>